Impact of the 7 Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. Pneumoniae in Healthy Jordanian Infants.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics; Therapeutic Use
- 01 Oct 2009 Planned number of patients changed from 300 to 377 as reported by ClinicalTrials.gov.
- 01 Oct 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 May 2009 New trial record